FNMAH Stock | News | Quote | Stock Forum | Thursday, October

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Overview of the Aluminum Alloy Wheel Market The Aluminum Alloy Wheel market has experienced notable growth and shows a bright future ahead. With ongoing innovations from manufacturers and shifting consumer preferences, the market is projected to reach approximately USD 33.2 billion by 2033. This growth translates to an estimated compound annual growth rate (CAGR) of 7.2%...

Global Icons to Speak at Fortune Global Forum 2024 Excitement is building around the upcoming Fortune Global Forum, where some of the most influential leaders in business and policy will converge. This event, set for November 11-12, promises rich dialogues on pressing global issues. Among the key figures attending are Tom Brady, the renowned seven-time world champion, and...

IGT Launches Exciting New Offerings for Wheel of Fortune International Game Technology PLC, better known as IGT, is famous for creating vibrant and engaging gaming experiences. At the upcoming Global Gaming Expo (G2E), IGT will proudly showcase a range of new products dedicated to the beloved Wheel of Fortune brand. Attendees can look forward to an exciting lineup that...

Understanding Short Selling for Walt Disney Walt Disney's short percent of float has experienced a notable increase, now standing at 8.04% from the latest report. Presently, there are 21.70 million shares sold short, which accounts for 1.21% of all available regular shares. With the current trading volume, it is estimated that it would take around 3.12 days on average for...

Heritage Commerce Corp Declares Dividend to Shareholders Heritage Commerce Corp (NASDAQ: HTBK), a respected bank holding company in the financial sector, recently shared exciting news with its stakeholders. The Board of Directors has approved a cash dividend of $0.13 per share for all common stock holders. This positive announcement reflects the company's commitment to...